These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9802972)

  • 21. Essential role of nitric oxide and interferon-gamma for tumor immunotherapy with interleukin-10.
    Sun H; Gutierrez P; Jackson MJ; Kundu N; Fulton AM
    J Immunother; 2000; 23(2):208-14. PubMed ID: 10746547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma.
    Hegardt P; Widegren B; Li L; Sjögren B; Kjellman C; Sur I; Sjögren HO
    Cancer Immunol Immunother; 2001 Nov; 50(9):491-501. PubMed ID: 11761444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma-dependent expression of inducible nitric oxide synthase, interleukin-12, and interferon-gamma-inducing factor in macrophages elicited by allografted tumor cells.
    Sanchez-Bueno A; Verkhusha V; Tanaka Y; Takikawa O; Yoshida R
    Biochem Biophys Res Commun; 1996 Jul; 224(2):555-63. PubMed ID: 8702426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells.
    Thibodeaux DK; Hunter SE; Waldburger KE; Bliss JL; Trepicchio WL; Sypek JP; Dunussi-Joannopoulos K; Goldman SJ; Leonard JP
    J Immunol; 1999 Nov; 163(10):5257-64. PubMed ID: 10553047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulation by interleukin-12 in MB49.1 tumor-bearing mice: cellular and cytokine-mediated effector mechanisms.
    Hunter SE; Waldburger KE; Thibodeaux DK; Schaub RG; Goldman SJ; Leonard JP
    Eur J Immunol; 1997 Dec; 27(12):3438-46. PubMed ID: 9464833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection.
    Dai WJ; Gottstein B
    Immunology; 1999 May; 97(1):107-16. PubMed ID: 10447721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A myeloid cell population induced by Freund adjuvant suppresses T-cell-mediated antitumor immunity.
    Wang Z; Jiang J; Li Z; Zhang J; Wang H; Qin Z
    J Immunother; 2010; 33(2):167-77. PubMed ID: 20145547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness.
    Orucevic A; Bechberger J; Green AM; Shapiro RA; Billiar TR; Lala PK
    Int J Cancer; 1999 Jun; 81(6):889-96. PubMed ID: 10362135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase.
    De Ridder M; Verovski VN; Chiavaroli C; Van den Berge DL; Monsaert C; Law K; Storme GA
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1473-80. PubMed ID: 17056198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
    Gabbai FB; Boggiano C; Peter T; Khang S; Archer C; Gold DP; Kelly CJ
    J Immunol; 1997 Dec; 159(12):6266-75. PubMed ID: 9550431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
    Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.
    Pannu R; Won JS; Khan M; Singh AK; Singh I
    J Neurosci; 2004 Jun; 24(26):5942-54. PubMed ID: 15229242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.
    Yu WG; Yamamoto N; Takenaka H; Mu J; Tai XG; Zou JP; Ogawa M; Tsutsui T; Wijesuriya R; Yoshida R; Herrmann S; Fujiwara H; Hamaoka T
    Int Immunol; 1996 Jun; 8(6):855-65. PubMed ID: 8671675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice.
    Orucevic A; Hearn S; Lala PK
    Lab Invest; 1997 Jan; 76(1):53-65. PubMed ID: 9010449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.
    Bekker LG; Freeman S; Murray PJ; Ryffel B; Kaplan G
    J Immunol; 2001 Jun; 166(11):6728-34. PubMed ID: 11359829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells.
    Prechel MM; Lozano Y; Wright MA; Ihm J; Young MR
    Cancer Immunol Immunother; 1996 May; 42(4):213-20. PubMed ID: 8665568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.
    van Den Broek M; Bachmann MF; Köhler G; Barner M; Escher R; Zinkernagel R; Kopf M
    J Immunol; 2000 Jan; 164(1):371-8. PubMed ID: 10605032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
    Chang MJ; Modzelewski RA; Russell DM; Johnson CS
    Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro.
    Johnson BD; Hanke CA; Becker EE; Truitt RL
    Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.